Zhiwei Yin
State Key Laboratory Of Kidney Diseases
Beijing, China
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Time in target range for body mass index and risk of new onset multimorbidity in middle-aged and older adults: a landmark analysis of two prospective cohorts.
Journal: Journal of global health
Published: April 23, 2026
Pretreatment of metanephric mesenchymal cells with catalpol mitigates acute kidney injury through VEGF-A secretion via multiple mechanisms.
Journal: Stem cell research & therapy
Published: August 12, 2025
Randomized, Single-Blind, Comparative Study of Remimazolam Besylate vs Propofol for Facial Plastic Surgery.
Journal: Aesthetic surgery journal
Published: February 10, 2024
Relationship between Traditional Chinese Medicine Syndrome Elements and Prognosis of Patients with IgA Nephropathy.
Journal: Evidence-based complementary and alternative medicine : eCAM
Published: April 15, 2022
Exploring the Underlying Mechanism of Shenyankangfu Tablet in the Treatment of Glomerulonephritis Through Network Pharmacology, Machine Learning, Molecular Docking, and Experimental Validation.
Journal: Drug design, development and therapy
Published: August 12, 2021
A novel lncRNA-miRNA-mRNA competing endogenous RNA regulatory network in lung adenocarcinoma and kidney renal papillary cell carcinoma.
Journal: Thoracic cancer
Published: July 30, 2021
Erratum to renal progenitor cells modulated by angiotensin II receptor blocker (ARB) medication and differentiation towards podocytes in anti-thy1.1 nephritis.
Journal: Annals of translational medicine
Published: August 15, 2020
Renal progenitor cells modulated by angiotensin II receptor blocker (ARB) medication and differentiation towards podocytes in anti-thy1.1 nephritis.
Journal: Annals of translational medicine
Published: May 02, 2020
Potential Association of Body Constitution with the Prognosis of IgA Nephropathy: A Long-Time Follow-Up of 203 Cases in China.
Journal: Evidence-based complementary and alternative medicine : eCAM
Published: February 26, 2019
Discovery of the Human Immunodeficiency Virus Type 1 (HIV-1) Attachment Inhibitor Temsavir and Its Phosphonooxymethyl Prodrug Fostemsavir.
Journal: Journal of medicinal chemistry
Published: June 20, 2018
Last Updated: 09/26/2026